Acute Leukemia - Multidrug Resistance Studies

CALGB 9760: Multidrug Resistance Studies in Acute Leukemia

Protocol ID

02-214

Protocol Description

This study will investigate whether some leukemia cells are resistant or become resistant to chemotherapy drugs that are used to treat leukemia. In addition, we hope to learn whether attempting to make leukemia cells more sensitive to chemotherapy drugs is likely to improve response to treatment.

Eligibility Criteria

Patients with acute leukemia

Primary Investigator(s)

  • Jonathan Kolitz, MD

Contact Information

Kerry Wallace
(516) 734-8913
kerry@nshs.edu

Last Update

March 26, 2010
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Cancer:
top